[stock_market_widget type="clock-markets" template="analog" timezone="America/New_York" title="New York" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/London" title="London" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/Brussels" title="Brussels" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Hong_Kong" title="Hong Kong" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Tokyo" title="Tokyo" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Australia/Sydney" title="Sydney" style="font-size: 7px; width: 100px;"]

Stock Market News

Alabama settles opioid claims against J&J, distributors for $276 million – attorney general

04/19/2022

Less than a minute

2022.04.19 21:16

Alabama settles opioid claims against J&J, distributors for $276 million - attorney general
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid

(Reuters) – Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corp (NYSE:MCK) and Endo Pharmaceutical, resolving the state’s claims that the companies fueled an opioid addiction crisis, the state Attorney General said.

Source

04/19/2022

Less than a minute